Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Director/PDMR Shareholding

21 Apr 2015 13:44

RNS Number : 8712K
FDM Group (Holdings) plc
21 April 2015
 



21 April 2015

FDM Group (Holdings) plc

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

PSP Award - 20 April 2015

On 20 April 2015 FDM Group (Holdings) plc ("FDM") granted awards over ordinary shares in the Company under the FDM 2014 Performance Share Plan (the "PSP"), as noted below.

The vesting of the awards is subject to the achievement of a performance condition based upon the annual compound growth in FDM's earnings per share over the three year performance period commencing with FDM's 2015 financial year. Ordinarily, the awards and options will vest (subject to the achievement of the performance conditions) following the announcement of FDM's results for its 2017 financial year.

Awards granted to participants in the UK have been structured as "Approved PSP" ("APSP") awards to take account of potential tax advantages for the participants and FDM. Each APSP award consists of a tax qualifying option under the FDM Company Share Option Plan (the "CSOP") over shares with a value of up to £30,000 and with an exercise price of £3.31 per share, a "Linked Award" under the PSP which is principally a funding award to fund the exercise price of the CSOP option and a separate award under the PSP in respect of the balance of the value of the award above £30,000, as noted below.

Each award (including the Linked Awards) under the PSP has been granted in the form of an option with an exercise price per share of £0.01

Name

Number of shares subject to PSP award

Number of shares subject to CSOP option (where applicable)

Maximum number of shares subject to linked award*

Executive Directors

Rod Flavell

40,937

9,063

9,063

Sheila Flavell

40,937

9,063

9,063

Andy Brown

40,937

9,063

9,063

Mike McLaren

40,937

9,063

9,063

Other Senior Managers

Andrew King

15,937

9,063

9,063

Claus Damwerth

25,000

N/A

N/A

Stewart Sharman

15,937

9,063

9,063

*Each Linked Award is principally to fund the exercise price of the CSOP option. If the CSOP option is exercised at a gain, the Linked Award will be exercisable over such number of shares as have a market value at the date of exercise equal to the aggregate exercise price of the CSOP option. If the CSOP option is not capable of exercise at a gain and is released, the Linked Award may be exercised in respect of the number of shares in respect of which it vests.

This notification is made pursuant to Disclosure and Transparency Rule 3.1.4.

 

Enquiries:

FDM

Mike McLaren - Chief Financial Officer

0203 056 8240

Weber Shandwick

Nick Oborne / Tom Jenkins

020 7067 0000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAALFALFSEFF
Date   Source Headline
16th Jun 20213:29 pmRNSDirector/PDMR Shareholding
10th Jun 20214:03 pmRNSDirector/PDMR Shareholding
13th May 202110:48 amRNSDirector Declaration
12th May 20219:30 amRNSPDMR Shareholding
28th Apr 20211:00 pmRNSResult of AGM
28th Apr 20217:00 amRNSAGM Statement
22nd Apr 20219:32 amRNSDirector/PDMR Shareholding
16th Apr 20218:54 amRNSHolding(s) in Company
13th Apr 20219:19 amRNSPDMR Shareholding
29th Mar 20214:34 pmRNSDirector Declaration
22nd Mar 20216:25 pmRNS2021 Notice of Annual General Meeting
11th Mar 20215:38 pmRNSPDMR Shareholding
10th Mar 20217:00 amRNSFinal Results
11th Feb 20211:05 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSTrading Update & Second Interim Dividend for 2020
12th Jan 20212:05 pmRNSDirector/PDMR Shareholding
30th Dec 202012:22 pmRNSDirector/PDMR Shareholding
3rd Dec 20202:43 pmRNSHolding(s) in Company
1st Dec 20205:41 pmRNSHolding(s) in Company
18th Nov 202012:27 pmRNSHolding(s) in Company
17th Nov 20203:09 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSThird Quarter Trading Update
8th Sep 202012:23 pmRNSDirector/PDMR Shareholding
2nd Sep 20203:18 pmRNSDirector/PDMR Shareholding
2nd Sep 20209:21 amRNSDirector Declaration
13th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20204:37 pmRNSDirector/PDMR Shareholding
30th Jul 202012:02 pmRNSPrice Monitoring Extension
29th Jul 20207:00 amRNSHalf-year Report
9th Jul 20203:06 pmRNSHolding(s) in Company
8th Jul 20203:00 pmRNSHolding(s) in Company
3rd Jul 202012:08 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
17th Jun 20205:41 pmRNSHolding(s) in Company
16th Jun 20202:04 pmRNSResult of AGM
16th Jun 20207:00 amRNSAGM Statement and Appointment of Joint Broker
3rd Jun 202011:38 amRNSHolding(s) in Company
29th May 20203:15 pmRNSHolding(s) in Company
7th May 20204:42 pmRNS2020 Notice of Annual General Meeting
1st May 20202:08 pmRNSBlock listing Interim Review
30th Apr 20207:00 amRNSFirst-Quarter Trading and COVID-19 Update
29th Apr 20202:03 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSHolding(s) in Company
27th Mar 20207:00 amRNSUpdate on Covid-19 re Dividend, AGM, Annual Report
11th Mar 20207:00 amRNSFinal Results
2nd Mar 20202:51 pmRNSTotal Voting Rights
29th Jan 20207:00 amRNSYear End Trading Update
2nd Jan 20204:03 pmRNSTotal Voting Rights
18th Dec 201910:53 amRNSDirectorate Change
10th Dec 20194:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.